MYND Mynd Analytics, Inc.

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Niihara Yutaka	2. Issuer Name and Ticker or Trading Symbol Emmaus Life Sciences, Inc. [ EMMA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    __X__ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chairman and CEO
(Last)          (First)          (Middle) 21250 HAWTHORNE BLVD., SUITE 800	3. Date of Earliest Transaction (MM/DD/YYYY) 8/26/2019
(Street) TORRANCE, CA 90503 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, $0.001 par value	8/26/2019		P		400	A	$3.11	1018566	D (1)
Common stock, $0.001 par value	8/26/2019		P		100	A	$3.14	1018666	D
Common stock, $0.001 par value	8/26/2019		P		400	A	$3.15	1019066	D
Common stock, $0.001 par value	8/26/2019		P		300	A	$3.16	1019366	D
Common stock, $0.001 par value	8/26/2019		P		900	A	$3.17	1020266	D
Common stock, $0.001 par value	8/26/2019		P		600	A	$3.18	1020866	D
Common stock, $0.001 par value	8/26/2019		P		100	A	$3.19	1020966	D
Common stock, $0.001 par value	8/26/2019		P		800	A	$3.20	1021766	D
Common stock, $0.001 par value	8/26/2019		P		1700	A	$3.215	1023466	D
Common stock, $0.001 par value	8/26/2019		P		200	A	$3.22	1023666	D
Common stock, $0.001 par value	8/26/2019		P		300	A	$3.26	1023966	D
Common stock, $0.001 par value	8/26/2019		P		100	A	$3.22	1024066	D
Common stock, $0.001 par value	8/26/2019		P		100	A	$3.33	1024166	D
Common stock, $0.001 par value	8/27/2019		P		5800	A	$2.59	1029966	D
Common stock, $0.001 par value	8/27/2019		P		100	A	$2.60	1030066	D
Common stock, $0.001 par value	8/27/2019		P		1200	A	$2.63	1031266	D
Common stock, $0.001 par value	8/27/2019		P		2004	A	$2.64	1033270	D
Common stock, $0.001 par value	8/27/2019		P		1000	A	$2.65	1034270	D
Common stock, $0.001 par value								10501	I	By Soomi Niihara
Common stock, $0.001 par value								92749	I	By Hope International Hospice, Inc. (2)
Common stock, $0.001 par value								46446	I	As custodian (3)
Common stock, $0.001 par value	8/27/2019		P		338	A	$2.66	1034608	D
Common stock, $0.001 par value	8/27/2019		P		3900	A	$2.665	1038508	D
Common stock, $0.001 par value	8/27/2019		P		50	A	$2.67	1038558	D
Common stock, $0.001 par value	8/27/2019		P		5263	A	$2.68	1043821	D
Common stock, $0.001 par value	8/27/2019		P		696	A	$2.69	1044517	D
Common stock, $0.001 par value	8/27/2019		P		100	A	$2.695	1044617	D
Common stock, $0.001 par value	8/27/2019		P		4049	A	$2.70	1048666	D
Common stock, $0.001 par value	8/27/2019		P		1000	A	$2.71	1049666	D
Common stock, $0.001 par value	8/27/2019		P		200	A	$2.72	1049866	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:
(1)	The shares shown and all other shares shown in this Report as owned directly include shares owned jointly with Soomi Niihara, the reporting person's wife.
(2)	Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.
(3)	The shares shown are held by Dr. Niihara as custodian for the benefit of his adult children. Dr. Niihara disclaims beneficial ownership of such shares. The inclusion in this Report of such shares shall not be deemed an admission that Dr. Niihara is the beneficial owners of such shares for purposes of Section 16 or for any other purpose.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Niihara Yutaka 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE, CA 90503	X	X	Chairman and CEO

Signatures
Yutaka Niihara, M.D., M.P.H.		8/27/2019
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} Share on Facebook Share on Twitter Share on Email